Leera Patel
Endocrinology, Diabetes & Metabolism · Lexington, KYNPI 1619932803
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $27,100 of the $33,792 with a category attached, or 80.2%. Lilly USA, LLC accounts for 96.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $33,651 and has fallen 99.6% since, to $125 in 2021.
Across 128 payments — averaging $264.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$32K
- Novo Nordisk$198
- Shire North American Group Inc$183
- Sanofi-aventis U.S. LLC$165
- AbbVie$155
- Amgen$121
- plus $488 from 13 others
What the payments were for
- Consulting fees$3,25010%
- Speaking & faculty fees$27,10080%
- Travel & lodging$1,4964%
- Food & beverage$1,9316%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 61 | $32,482 |
| Novo Nordisk | 3 | $198 |
| Shire North American Group Inc | 10 | $183 |
| Sanofi-aventis U.S. LLC | 11 | $165 |
| AbbVie | 8 | $155 |
| Amgen | 1 | $121 |
| Corcept Therapeutics | 5 | $80 |
| Boehringer Ingelheim | 5 | $66 |
| Merck | 5 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| Dexcom, Inc. | 3 | $45 |
| Johnson & Johnson | 3 | $44 |
| Insulet Corporation | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $26 |
| Abbott | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Mannkind Corporation | 1 | $14 |
| IBSA Pharma Inc. | 1 | $14 |
| Senseonics, Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,792 in reported general payments places this provider in the 85th percentile of 90 endocrinology, diabetes & metabolism providers in Kentucky.
See all endocrinology, diabetes & metabolism providers in Kentucky →
Other endocrinology, diabetes & metabolism in Lexington
- Lyle MyersLexington$60K
- Wendell MiersLexington$38K
- Simon FisherLexington$26K
- Anna MarinoLexington$23K
- Gordon GuthrieLexington$14K
- Kenneth AinLexington$5K
- Megan MinchLexington$4K
- Walaa AyoubLexington$3K
- Kristina HumphriesLexington$3K
- Dennis KarounosLexington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.